Template:Clinically Utilized Antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 93: | Line 93: | ||
}} | }} | ||
| group3 = [[Aminoglycosides]] | | group3 = [[Aminoglycosides]] | ||
| Line 189: | Line 183: | ||
* [[Metronidazole]] | * [[Metronidazole]] | ||
* [[Rifampin]] | * [[Rifampin]] | ||
* [[Vancomycin]] | |||
}}<noinclude> | }}<noinclude> | ||
Revision as of 20:23, 25 March 2014
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hlist
How to manage this template's visibility
- Use
{{Clinically Utilized Antibiotics |state=collapsed}}to show this template in its collapsed (hidden) state. - Use
{{Clinically Utilized Antibiotics |state=expanded}}to show this template in its expanded (fully visible) state. - Use
{{Clinically Utilized Antibiotics |state=autocollapse}}to show this template in its collapsed (hidden) state only if there is another template of the same type on the page. - Unless set otherwise (see state parameter within the template's code), autocollapse is the default state.